Andrej Jančařík
Academy of Sciences of the Czech Republic
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrej Jančařík.
Angewandte Chemie | 2013
Andrej Jančařík; Jiří Rybáček; Kevin Cocq; Jana Vacek Chocholoušová; Jaroslav Vacek; Radek Pohl; Lucie Bednárová; Pavel Fiedler; Ivana Císařová; Irena G. Stará; Ivo Starý
Spiraling up: Easy access to dibenzo[5]-, dibenzo[6]-, and dibenzo[7]helicenes as well as their functionalized derivatives includes Sonogashira and Suzuki-Miyaura couplings, desilylation, and [2+2+2] alkyne cycloisomerization. The simplicity of this non-photochemical approach combined with the potential for helicity control favors dibenzohelicenes over the parent helicenes for practical applications.
Angewandte Chemie | 2012
Jaroslav Žádný; Andrej Jančařík; Angelina Andronova; Michal Šámal; Jana Vacek Chocholoušová; Jaroslav Vacek; Radek Pohl; David Šaman; Ivana Císařová; Irena G. Stará; Ivo Starý
The lack of a general method for the effective synthesis of nonracemic helicenes and their analogues has been a major hurdle that has limited a wider exploitation of these helically chiral aromatic systems in enantioselective catalysis, molecular recognition, self-assembly, surface science, chiral materials, and other branches of science. Ideally, a practical asymmetric synthesis would be independent of both the length of the helical backbone and the presence of functional groups. Since the pioneering studies by Martin et al. and Katz et al. , who successfully used diastereoselective photodehydrocyclization of stilbene-type precursors, various concepts of the asymmetric synthesis of helicenes have been explored but no general procedure for obtaining optically pure helicenes or their analogues with a wide structural diversity has yet been reported. Recently, we demonstrated diastereoselective [2+2+2] cycloisomerization of centrally chiral triynes to receive nonracemic helicene-like compounds with incorporated dihydrooxepine or dihydroazepine ring(s). This promising approach, however, has not yet reached the merit of being general and practical. Herein, we present fundamental progress in this endeavor to receive optically pure and functionalized [5]-, [6]-, and [7]heterohelicenes by means of asymmetric synthesis. With the aim of keeping the molecular shape of the helicene analogues as close as possible to that of the parent helicenes, such as 1 (Figure 1), we proposed embedding two
Chemistry: A European Journal | 2015
Michal Buchta; Jiří Rybáček; Andrej Jančařík; Amit A. Kudale; Miloš Buděšínský; Jana Vacek Chocholoušová; Jaroslav Vacek; Lucie Bednárová; Ivana Císařová; Graham J. Bodwell; Ivo Starý; Irena G. Stará
Chimerical pyrene-based dibenzo[7]helicene rac-1 and 2H-pyran[7]helicene (M,R,R)-(-)-2, in which two pyrene subunits are fused to the [7]helicene/[7]heterohelicene scaffold, were synthesised by means of Ni(0) - or Co(I) -mediated [2+2+2] cycloisomerisation of dipyrenyl-acetylene-derived triynes. Pyrene-based dibenzo[7]helicene 1 was obtained in enantioenriched form by enantioselective cycloisomerisation under Ni(0) /QUINAP catalysis (57 % ee) or in enantiopure form by racemate resolution by liquid chromatography on a chiral column. 1,3-Allylic-type strain-controlled diastereoselective cycloisomerisation was employed in the synthesis of enantiopure (M,R,R)-(-)-2. Physicochemical properties of 1 and 2 encompassing the helicity assignment, stability to racemisation, X-ray crystal structure, UV/Vis, experimental/calculated electronic circular dichroism and fluorescence spectra were studied. Accordingly, comparison of the X-ray crystal structure of (M,R,R)-(-)-2 with calculated structures (DFT: B3LYP/cc-pVDZ, B97D/cc-pVDZ) indicated that its helical backbone is slightly over-flattened owing to intramolecular dispersion forces between tert-butylated pyrene subunits. Both 1 and 2 are fluorescent (with quantum yields in dichloromethane of ΦF =0.10 and 0.17, respectively) and are suggested to form intramolecular excimer states upon excitation, which are remarkably stabilised and exhibit large Stokes shifts (296 and 203 nm, respectively).
Nature Chemistry | 2017
Oleksandr Stetsovych; Martin Švec; Jaroslav Vacek; Jana Chocholousova; Andrej Jančařík; Jiří Rybáček; Krzysztof Kosmider; Irena G. Stará; Pavel Jelínek; Ivo Starý
The chirality of molecular structures is paramount in many phenomena, including enantioselective reactions, molecular self-assembly, biological processes and light or electron-spin polarization. Flat prochiral molecules, which are achiral in the gas phase or solution, can exhibit adsorption-induced chirality when deposited on surfaces. The whole array of such molecular adsorbates is naturally racemic as spontaneous global mirror-symmetry breaking is disfavoured. Here we demonstrate a chemical method of obtaining flat prochiral molecules adsorbed on the solid achiral surface in such a way that a specific adsorbate handedness globally dominates. An optically pure helical precursor is flattened in a cascade of on-surface reactions, which enables chirality transfer. The individual reaction products are identified by high-resolution scanning-probe microscopy. The ultimate formation of globally non-racemic assemblies of flat molecules through stereocontrolled on-surface synthesis allows for chirality to be expressed in as yet unexplored types of organic-inorganic chiral interfaces.
Chemistry: A European Journal | 2016
Jiří Klívar; Andrej Jančařík; David Šaman; Radek Pohl; Pavel Fiedler; Lucie Bednárová; Ivo Starý; Irena G. Stará
We have developed a methodology for the synthesis of pyridohelicenes and their analogues based on the Ni(0) -, Co(I) - or Rh(I) -mediated intramolecular [2+2+2] cycloisomerisation of cyanodiynes. It allows for folding the linear precursors into the corresponding helical backbones comprising the newly formed pyridine unit in their central part. Along with racemic pyrido[n]helicenes (n=5,6,7) and their derivatives, both enantio- and diastereomerically pure pyrido[n]helicene-like molecules (n=5,6) were prepared by employing the chiral substrate-controlled cyclisation of the corresponding enantiopure cyanodiynes.
Chemical Communications | 2014
Anna L. Pinardi; José I. Martínez; Andrej Jančařík; Irena G. Stará; Ivo Starý; María Francisca López; Javier Méndez; José A. Martín-Gago
We report on the stepwise formation of N-doped nanohelicenes, nanographenes, nanodomes and graphenes from the same heteroaromatic precursor through subsequent dehydrogenations on Pt(111) upon thermal annealing. The combined experimental (UHV-STM) and computational (DFT) studies provide a full atomistic description of the intermediate reaction stages.
Journal of Medicinal Chemistry | 2016
Rana Rais; Andrej Jančařík; Lukáš Tenora; Michael T. Nedelcovych; Jesse Alt; Judson Englert; Camilo Rojas; Anne Le; Amira Elgogary; Jessica Tan; Lenka Monincová; Kelly A. Metcalf Pate; Robert J. Adams; Dana Ferraris; Jonathan D. Powell; Pavel Majer; Barbara S. Slusher
The glutamine antagonist 6-diazo-5-oxo-l-norleucine (DON, 1) has shown robust anticancer efficacy in preclinical and clinical studies, but its development was halted due to marked systemic toxicities. Herein we demonstrate that DON inhibits glutamine metabolism and provides antitumor efficacy in a murine model of glioblastoma, although toxicity was observed. To enhance DONs therapeutic index, we utilized a prodrug strategy to increase its brain delivery and limit systemic exposure. Unexpectedly, simple alkyl ester-based prodrugs were ineffective due to chemical instability cyclizing to form a unique diazo-imine. However, masking both DONs amine and carboxylate functionalities imparted sufficient chemical stability for biological testing. While these dual moiety prodrugs exhibited rapid metabolism in mouse plasma, several provided excellent stability in monkey and human plasma. The most stable compound (5c, methyl-POM-DON-isopropyl-ester) was evaluated in monkeys, where it achieved 10-fold enhanced cerebrospinal fluid to plasma ratio versus DON. This strategy may provide a path to DON utilization in glioblastoma multiforme patients.
Journal of Medicinal Chemistry | 2015
Jan Tykvart; Jiří Schimer; Andrej Jančařík; Jitka Bařinková; Václav Navrátil; Jana Starková; Karolína Šrámková; Jan Konvalinka; Pavel Majer; Pavel Šácha
We present here a structure-aided design of inhibitors targeting the active site as well as exosites of glutamate carboxypeptidase II (GCPII), a prostate cancer marker, preparing potent and selective inhibitors that are more than 1000-fold more active toward GCPII than its closest human homologue, glutamate carboxypeptidase III (GCPIII). Additionally, we demonstrate that the prepared inhibitor conjugate can be used for sensitive and selective imaging of GCPII in mammalian cells.
Chemistry: A European Journal | 2014
Serghei Chercheja; Jiří Klívar; Andrej Jančařík; Jiří Rybáček; Simon Salzl; Ján Tarábek; Lubomír Pospíšil; Jana Vacek Chocholoušová; Jaroslav Vacek; Radek Pohl; Ivana Císařová; Ivo Starý; Irena G. Stará
A cobalt-mediated [2+2+2] cycloisomerisation of ynedinitriles to helical pyridazines in good to high yields was developed. The construction of the pyridazine nucleus from one alkyne and two nitrile units is proposed to follow either a conventional organometallic mechanism or to be triggered by a single-electron transfer from a Co(II) species. Various [5]-, [6]- and [7]helicene pyridazines were prepared.
Journal of Medicinal Chemistry | 2016
Pavel Majer; Andrej Jančařík; Marcela Krečmerová; Tomáš Tichý; Lukáš Tenora; Krystyna M. Wozniak; Ying Wu; Elie Pommier; Dana Ferraris; Rana Rais; Barbara S. Slusher
2-Phosphonomethylpentanedioic acid (1, 2-PMPA) is a potent inhibitor of glutamate carboxypeptidase II which has demonstrated robust neuroprotective efficacy in many neurological disease models. However, 1 is highly polar containing a phosphonate and two carboxylates, severely limiting its oral bioavailability. We strategized to mask the polar groups via a prodrug approach, increasing the likelihood of passive oral absorption. Our initial strategy was to cover the phosphonate with hydrophobic moieties such as pivaloyloxymethyl (POM) and isopropyloxycarbonyloxymethyl (POC) while keeping the α- and γ-carboxylates unsubstituted. This attempt was unsuccessful due to the chemical instability of the bis-POC/POM derivatives. Addition of α,γ-diesters and α-monoesters enhanced chemical stability and provided excellent oral exposure in mice, but these mixed esters were too stable in vivo, resulting in minimal release of 1. By introducing POC groups on both the phosphonate and α-carboxylate, we synthesized Tris-POC-2-PMPA (21b), which afforded excellent release of 1 following oral administration in both mice and dog.